Cutaquig is a Subcutaneous Solution in the Plasma Derivative category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Human Immunoglobulin G.
Product ID | 0069-1476_0f26c79f-3d04-7c5c-d75d-bff9405f4dff |
NDC | 0069-1476 |
Product Type | Plasma Derivative |
Proprietary Name | Cutaquig |
Generic Name | Immunoglobulin G |
Dosage Form | Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2019-09-13 |
Marketing Category | BLA / BLA |
Application Number | BLA125668 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Active Ingredient Strength | 165 mg/mL |
Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2019-09-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125668 |
Product Type | LOT DISTRIBUTION DATA |
Billing Unit | ML |
Marketing Start Date | 2019-09-13 |
Marketing Category | BLA |
Application Number | BLA125668 |
Product Type | LOT DISTRIBUTION DATA |
Billing Unit | ML |
Marketing Start Date | 2019-09-13 |
Ingredient | Strength |
---|---|
HUMAN IMMUNOGLOBULIN G | 165 mg/mL |
NDC | Brand Name | Generic Name |
---|---|---|
0069-1061 | Cutaquig | immunoglobulin G |
0069-1476 | Cutaquig | immunoglobulin G |
0069-1509 | Cutaquig | immunoglobulin G |
0069-1802 | Cutaquig | immunoglobulin G |
0069-1960 | Cutaquig | immunoglobulin G |
0069-1965 | Cutaquig | immunoglobulin G |
68982-810 | Cutaquig | immunoglobulin G |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CUTAQUIG 87225330 5880441 Live/Registered |
Octapharma AG 2016-11-03 |